X4 Pharmaceuticals Inc (XFOR) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $3.25
• Market Cap: $300.78M
• EPS: $-8.92
• 52-Week High: $12.54
• 52-Week Low: $1.35

Market Sentiment

X4 Pharmaceuticals Inc currently has a Bullish sentiment score of 0.16.

About X4 Pharmaceuticals Inc

X4 Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm based in Boston, Massachusetts, focused on developing innovative therapies for rare and serious diseases, particularly in the realm of back disorders. The company employs its proprietary biology to create cutting-edge treatments aimed at enhancing patient outcomes. With a robust pipeline of investigational therapies progressing through various clinical development phases, X4 is strategically positioned to address significant ...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for X4 Pharmaceuticals Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does XFOR pay dividends?

X4 Pharmaceuticals Inc (XFOR) does not currently pay a regular dividend.

What is XFOR's market cap?

X4 Pharmaceuticals Inc (XFOR) has a market capitalization of $300.78M with a current stock price of $3.25.